News and Press Releases

Groundbreaking myalgic encephalomyelitis study identifies over 250 core genes, shared biology with long COVID, and dozens of drug repurposing opportunities

The study reinforces that ME is a complex multisystemic condition with a clear genetic basis and lays the foundation for future clinical trials that could be faster to recruit and...

Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: December 4, 2025

8b Bankside Hanborough Business Park Oxford, OX29 8LJ

Groundbreaking myalgic encephalomyelitis study identifies over 250 core genes, shared biology with long COVID, and dozens of drug repurposing opportunities

The study reinforces that ME is a complex multisystemic condition with a clear genetic basis and lays the foundation for future clinical trials that could be faster to recruit and...

Category: BioManufacturing, Clinical Trials, Other, Pharmaceutical
Posted: December 4, 2025

8b Bankside Hanborough Business Park Oxford, OX29 8LJ

PrecisionLife and Metrodora Institute share first insights with ME/CFS, Long COVID participants in MetX research study

MetX funded by $1M grant from Metrodora Foundation to accelerate research for complex multisystem disorders 18 September 2024 -- Utah, US, and Oxford, UK -- PrecisionLife, a leading clinical-stage precision...

Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 18, 2024

8b Bankside Hanborough Business Park Oxford, OX29 8LJ

PrecisionLife and Metrodora Institute Launch Clinical Trials to Accelerate the Diagnosis and Treatment of ME/CFS and Long-COVID-19 Patients

Up to 1,000 patients being recruited into targeting precision medicine clinical trials expected to readout results as early as this year Trials are designed to provide validation of safety and...

Category: Biotechnology, Clinical Trials
Posted: May 14, 2024

8b Bankside Hanborough Business Park Oxford, OX29 8LJ